Search

Your search keyword '"Barrios C."' showing total 1,279 results

Search Constraints

Start Over You searched for: Author "Barrios C." Remove constraint Author: "Barrios C."
1,279 results on '"Barrios C."'

Search Results

5. Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial

7. A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial

8. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

9. On the PI-PBC Controllers for a High-Gain Transformerless DC-DC Converter

12. Method comparison of complement C3 chemiluminescent assay between Atellica CH and dimension vista (siemens healthineers)

13. Method comparison of ceruloplasmin chemiluminescent assay between Atellica CH and dimension vista (siemens healthineers)

14. Method comparison of anti-streptolysin O chemiluminescent assay between Atellica CH and dimension vista (siemens healthineers)

15. Method comparison of alpha-1-acid glycoprotein chemiluminescent assay between Atellica CH and dimension vista (siemens healthineers)

16. Precocious puberty in a patient diagnosed with neonatal steinert syndrome: A case report

17. ELF – Enhanced Liver Fibrosis test (Siemens Healthineers) demonstrates an incremental sensitivity and specificity directly proportional to the degree of fibrosis

18. MYC/BCL2/BCL6 triple hit lymphoma: Rare finding in cerebrospinal fluid without apparent involvement in bone marrow or peripheral blood

19. Method comparison of beta-2 microglobulin chemiluminescent assay between Atellica CH and dimension vista (siemens healthineers)

20. Method comparison of alpha-1-antitrypsin chemiluminescent assay between Atellica CH and dimension vista (siemens healthineers)

22. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

24. Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

35. National analysis of testicular and scrotal trauma in the USA

41. LBA1 Final analysis of the placebo-controlled randomised phase III IMpassion031 trial evaluating neoadjuvant atezolizumab (atezo) plus chemotherapy (CT) followed by open-label adjuvant atezo in patients (pts) with early-stage triple-negative breast cancer (eTNBC)

Catalog

Books, media, physical & digital resources